• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 35 of 100
Gilead remdesivir coronavirus FDA
HealthGilead says remdesivir slashes coronavirus deaths. But it’s complicated
By Sy MukherjeeJuly 10, 2020
HealthYou can now sign up to participate in COVID-19 vaccine clinical trials
By Jonathan VanianJuly 8, 2020
CommentaryIn the COVID-19 vaccine race, nobody wins unless everyone wins
By Seth BerkleyJuly 8, 2020
FinanceA dose of good news: Pfizer shares surge on coronavirus vaccine trial
By Rey MashayekhiJuly 1, 2020
Gilead remdesivir coronavirus FDA
HealthCOVID treatment remdesivir will cost $520 per vial. But it may not be how much you pay
By Sy MukherjeeJune 29, 2020
Gilead coronavirus treatment drug Remdesivir
HealthGilead to charge thousands for coronavirus treatment drug that critics say should cost $1
By Robert Langreth and BloombergJune 29, 2020
Gilead inhaled remdesivir trial
HealthGilead’s next COVID-19 treatment advancement could keep patients out of hospitals
By Sy MukherjeeJune 22, 2020
HealthCourt rules Trump can’t require drugmakers to disclose prices in TV ads
By The Associated PressJune 18, 2020
ADHD video game Akili FDA
HealthHow the first-ever digital ADHD treatment—a video game—got the FDA’s blessing
By Sy MukherjeeJune 17, 2020
Second wave coronavirus
NewslettersA second coronavirus wave isn’t imminent—the first one never ended
By Sy MukherjeeJune 11, 2020
AstraZeneca Gilead deal
HealthRumors swirl about an AstraZeneca and Gilead megadeal—but it doesn’t make sense
By Sy MukherjeeJune 8, 2020
Health5 companies to keep an eye on following the world’s largest cancer conference
By Sy MukherjeeJune 3, 2020
FinanceFrance’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
By James Paton, Riley Griffin and BloombergMay 26, 2020
Hydroxychloroquine study shows deaths, heart risks in COVID-19 patients
HealthHydroxychloroquine linked to deaths and heart risks in new COVID-19 study after Trump touted and claimed to be taking the drug
By John Lauerman and BloombergMay 22, 2020
Moderna Therapeutics coronavirus vaccine
NewslettersModerna’s coronavirus vaccine expectations game
By Sy MukherjeeMay 21, 2020
1...
  • 33
  • 34
  • 35
  • 36
  • 37
...100
Most Popular
Economy
Elon Musk warns the U.S. is '1,000% going to go bankrupt' unless AI and robotics save the economy from crushing debtAn image of a popular article
By Jason MaFebruary 7, 2026
Success
Even with $850 billion to his name, Elon Musk admits ‘money can’t buy happiness.’ But billionaire Mark Cuban says it’s not so simpleAn image of a popular article
By Preston ForeFebruary 6, 2026
Success
Gen Z Patriots quarterback Drake Maye still drives a 2015 pickup truck even after it broke down on the highway—despite his $37 million contractAn image of a popular article
By Sasha RogelbergFebruary 7, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.